We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

New Testosterone, Steroid Labels To Warn Of Abuse, Dependence, FDA Says In Warning

(October 26, 2016, 1:47 PM EDT) -- SILVER SPRING, Md. — The Food and Drug Administration on Oct. 24 said it approved classwide labeling changes for all prescription testosterone products and anabolic androgenic steroids (AAS) to warn about the risk of abuse and dependence.

The FDA said labels will include “new safety information from published literature and case reports regarding the risks associated with abuse and dependence of testosterone and other AAS.”

The FDA said the Anabolic Steroids Control Act of 1990 placed AAS, including testosterone, in Schedule III of the Controlled Substances...
To view the full article, register now.